A characteristic feature of autoimmune diseases is the presence of multiple antibodies.
Antibody profiling can be advantageous for the early diagnosis and for a more precise …

A paradigmatic feature of autoimmune rheumatic diseases (ARD) is the presence of multiple
autoantibodies. The use of antibody profiles in the study of ARD therefore should be the best …

Proteomics technologies enable profiling of autoantibody responses using biological fluids
derived from patients with autoimmune disease. They provide a powerful tool to characterize …

In autoimmune rheumatic diseases (ARDs), the autoantibodies provide classification and
diagnostic criteria and are used both to define the prognosis and as markers for disease …

A hallmark of autoimmune diseases is the production of high titers of highly specific
autoantibodies, which are routinely measured to guide clinical decision-making. Multiplex …

Array technology and proteomics are about to launch the era of multiplexed analysis, which
allows simultaneous detection of numerous autoantibody specificities and the possibility of …

Advances in immunoassay technologies offer many opportunities for understanding the
relationship between autoantibody detection and the myriad complex, clinical phenotypes …

Initial characterization of autoimmune rheumatic disease through clinical assessment and
investigation including serological measurements offers a vital opportunity to personalize …

Initial characterization of autoimmune rheumatic disease through clinical assessment and
investigation including serological measurements offers a vital opportunity to personalize …

Autoantibodies produced against self-antigens, or 'autoantigens', result from a loss of
selftolerance triggered by genetic and/or environmental factors which induce the immune …